Clinical Trial Update: Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy. [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating topical insulin drops for neurotrophic keratopathy has been withdrawn after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotrophic Keratitis

Snippet

Sponsor: University of Alberta | Conditions: Neurotrophic Keratitis | Phase 2, Phase 3 | Status: WITHDRAWN